Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Cayman
STING H232 variant (human, recombinant)
909
CHF
CHF 909.00
In stock
CAY-22815-100100 µgCHF 909.00
Product Details | |
---|---|
Synonyms | Endoplasmic Reticulum Interferon Stimulator; ERIS; hSTING; MITA; MPYS; Stimulator of Interferon Genes; TMEM173 |
Product Type | Protein |
Properties | |
Sequence | Recombinant N-terminal His-tagged STING (H232 variant) catalytic domain purified from E. coli. |
Purity | ≥70% (SDS-PAGE) |
Formulation | 50 mM HEPES, pH 8.0, 150 mM sodium chloride, 10% glycerol |
Other Product Data |
Click here for Original Manufacturer Product Datasheet |
Declaration | Manufactured by Cayman Chemicals. |
Shipping and Handling | |
Shipping | DRY ICE |
Long Term Storage | -80°C |
Documents | |
MSDS | Inquire |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
Stimulator of interferon genes (STING) is a component of the innate immune response that binds to cyclic dinucleotides, which are bacterial second messengers, leading to activation of NF-κB and transcription of immunomodulatory genes, including type I interferon (IFN). The H232 variant of STING is found at a 13.7% frequency in the 1000 Genome Project. The SNP variant R232 is the most common variant in the human population, found at a frequency of 57.9%. Various mutations in STING either reduce or increase its activity. Gain-of-function mutations in STING, including R284M and V155M, lead to constitutive activation and enhancement of the type I IFN response.